中国标准化Issue(4)：289-292,4.DOI:10.3969/j.issn.1002-5944.2024.04.063
头孢西丁钠联合康妇消炎栓在盆腔炎规范化治疗中的应用
Application of Cefoxitin Sodium Combined with Kangfu Anti-inflammatory Suppository in Standardized Treatment of Pelvic Inflammatory Disease
摘要
Abstract
Objective:To explore the efficacy of cefoxitin sodium combined with kangfu anti-inflammatory suppository in the standardized treatment of pelvic inflammatory disease.Methods:A total of 80 patients with pelvic inflammatory disease admitted to the Obstetrics and Gynecology Department of Minqin County Community Health Service Center from February 2023 to October 2023 were selected as the research objects and divided into the control group and the experimental group according to random average grouping,with 40 cases in each group.The experimental group received cefoxitin sodium combined with kangfu anti-inflammatory suppository treatment,and the control group received only cefoxitin sodium treatment.The inflammation and incidence of adverse reactions before and after diagnosis and treatment were compared between the two groups.Results:After treatment,the levels of tumor necrosis factor(TNF-α)and C-reactive protein(CRP),the diameter of inflammatory mass and the depth of pelvic fluid in the two groups were decreased,and the experimental group was significantly lower than the control group(P<0.05).Interleukin-2(IL-2)was increased in both groups,and the experimental group was significantly higher than the control group(P<0.05).The incidence of adverse reactions in the control group was slightly higher than that in the experimental group(P>0.05).Conclusion:Cefoxitin sodium combined with kangfu anti-inflammatory suppository has a significant effect in the standardized treatment of patients with pelvic inflammatory disease,which can improve the inflammatory response and relieve the clinical symptoms.关键词
康妇消炎栓/头孢西丁钠/盆腔炎Key words
kangfu anti-inflammatory suppository/cefoxitin sodium/pelvic inflammatory disease引用本文复制引用
王春霞..头孢西丁钠联合康妇消炎栓在盆腔炎规范化治疗中的应用[J].中国标准化,2024,(4):289-292,4.
